X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AVIR

Closed

Atea Pharmaceuticals inc

3.6
0.0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.6
Day's Range: 3.535 - 3.65
Send
When Written:
 
3.35
Atea Pharmaceuticals Inc is a biopharmaceutical company that focuses on discovering and developing antiviral therapeutics for the treatment of life-threatening viral infections. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Atea Pharmaceuticals' lead product candidate is AT-527, an oral direct-acting antiviral (DAA) agent for the treatment of COVID-19. The company is also developing other antiviral candidates for the treatment of hepatitis C virus (HCV) and respiratory syncytial virus (RSV).

In addition to its drug development programs, Atea Pharmaceuticals has partnerships with several leading pharmaceutical companies and research institutions. The company has received funding from various sources, including venture capital firms and government agencies.

Atea Pharmaceuticals is led by a team of experienced executives and scientists with a track record of success in drug discovery and development. The company is committed to advancing innovative therapies for viral diseases that have a significant impact on global health.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X